Kilicarslan, A. Et Al. 2003. Clinical importance of vascular endothelial growth factor (VEGF) for papillary thyroid carcinomas. APMIS , vol.111, no.3 , 439-443.

Kilicarslan, A., OGUS, M., Arici, C., Pestereli, H. E., CAKIR, M., & KARPUZOGLU, G., (2003). Clinical importance of vascular endothelial growth factor (VEGF) for papillary thyroid carcinomas. APMIS , vol.111, no.3, 439-443.

Kilicarslan, BAHAR Et Al. "Clinical importance of vascular endothelial growth factor (VEGF) for papillary thyroid carcinomas," APMIS , vol.111, no.3, 439-443, 2003

Kilicarslan, BAHAR Et Al. "Clinical importance of vascular endothelial growth factor (VEGF) for papillary thyroid carcinomas." APMIS , vol.111, no.3, pp.439-443, 2003

Kilicarslan, A. Et Al. (2003) . "Clinical importance of vascular endothelial growth factor (VEGF) for papillary thyroid carcinomas." APMIS , vol.111, no.3, pp.439-443.

@article{article, author={BAHAR AKKAYA Et Al. }, title={Clinical importance of vascular endothelial growth factor (VEGF) for papillary thyroid carcinomas}, journal={APMIS}, year=2003, pages={439-443} }